Evaluation of the pharmacokinetics of ixabepilone for the treatment of breast cancer-Reference-Cited by-同舟云学术

Evaluation of the pharmacokinetics of ixabepilone for the treatment of breast cancer

Published:2015-06-15 Issue:7 Volume:11 Page:1177-1185
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

De Luca Antonella,D’Alessio Amelia,Maiello Monica Rosaria,Gallo Marianna,Chicchinelli Nicoletta,Pergameno Maria,Piccirilli Maria Sofia,Normanno Nicola

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2015.1057497

Reference55 articles.

1. Third consensus on medical treatment of metastatic breast cancer

2. Cancer drug resistance: an evolving paradigm

3. Epothilons A and B: Antifungal and Cytotoxic Compounds from Sorangium cellulosum (Myxobacteria). Production, Physico-chemical and Biological Properties.

4. Recent Developments in the Chemical Biology of Epothilones

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies;Cancers;2024-08-06

2. Development of HPLC Method for Ixabepilone (Oncology Drug) in Bulk and Dosage Form: Quantification of Impurities and Forced Degradation Studies;Journal of Chromatographic Science;2023-07-18

3. A validated stability‐indicating reversed‐phase liquid chromatography method for the quantification of Ixabepilone (Oncology drug) in the parenteral dosage form;SEPARATION SCIENCE PLUS;2023-02-09

4. UPLC‐PDA coupled HR‐TOF ESI/MS 2 ‐based identification of derivatives produced by whole‐cell biotransformation of epothilone A using Nocardia sp. CS692 and a cytochrome P450 overexpressing strain;Biotechnology and Applied Biochemistry;2021-09-02

5. PTPRT Could Be a Treatment Predictive and Prognostic Biomarker for Breast Cancer;BioMed Research International;2021-08-10